Vanguard Global Advisers
CELU icon

Vanguard Global Advisers’s Celularity CELU Stock Holding History

Vanguard Global Advisers’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38K Hold
2,315
– – ﹤0.01% 3611
2026
Q1 		$3.08K Buy
+2,315
New +$2.93K ﹤0.01% 3594

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Vanguard Global Advisers's CELU Position: Q2 2026 in Review

Vanguard Global Advisers held its Celularity (CELU) position steady in Q2 2026 at 2,315 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #3611.

Vanguard Global Advisers first reported a position in CELU in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.08K in Q1 2026. 40 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Vanguard Global Advisers held 2,315 shares of Celularity worth $1.38K as of Q2 2026.
  • Vanguard Global Advisers left its Celularity share count unchanged in Q2 2026.
  • Celularity made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3611 holding.
  • Vanguard Global Advisers first reported a position in Celularity in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Celularity position peaked at $3.08K in Q1 2026.
  • 40 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.